1. Home
  2. AURA vs LAES Comparison

AURA vs LAES Comparison

Compare AURA & LAES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$5.28

Market Cap

396.8M

Sector

Health Care

ML Signal

HOLD

Logo SEALSQ Corp

LAES

SEALSQ Corp

HOLD

Current Price

$4.22

Market Cap

366.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AURA
LAES
Founded
2007
2022
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
396.8M
366.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
AURA
LAES
Price
$5.28
$4.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$20.20
$6.50
AVG Volume (30 Days)
178.6K
9.2M
Earning Date
11-13-2025
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,978,000.00
Revenue This Year
N/A
$66.73
Revenue Next Year
N/A
$92.76
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$1.99
52 Week High
$8.60
$9.50

Technical Indicators

Market Signals
Indicator
AURA
LAES
Relative Strength Index (RSI) 32.59 48.21
Support Level $5.30 $3.71
Resistance Level $6.34 $4.76
Average True Range (ATR) 0.36 0.32
MACD -0.10 0.01
Stochastic Oscillator 5.00 50.00

Price Performance

Historical Comparison
AURA
LAES

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About LAES SEALSQ Corp

SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America.

Share on Social Networks: